Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
Scientists from NCATS and Sweden’s Karolinska Institutet have developed a potential new approach to fighting cancer by breaking down a defense system used by cancer cells.
NCATS supports rare disease patients and their communities by providing research funding, tools and other resources to help address their unique challenges.
NCATS is leading trans-agency efforts for NIH’s new Somatic Cell Genome Editing program that aims to develop tools for safe and effective genome editing in human patients.
Read about NCATS’ support for a promising new gene therapy, a potential strategy against Huntington’s disease, Rare Disease Day at NIH, a CTSA Program scholar, and more.
This March 1, 2018 event features interactive panel discussions, posters, exhibits, tours and more. Register now.
NIH Collaboration Leverages CTSA Program for Research Mentoring
NCATS Collaboration Enables Gene Therapy to Move to Clinical Trial
Christopher P. Austin, M.D.
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program (PDF - 80KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …